We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Central Blood Pressure a Good Indicator of LVH Development

By HospiMedica International staff writers
Posted on 16 Feb 2010
A new study claims that central blood pressure (CPB) is a more important indicator of the development of left ventricular hypertrophy (LVH) than is brachial (pulse) blood pressure.

Researchers at Weill Cornell Medical College (New York, NY, USA) conducted an analysis involving 2,585 American Indian participants of the fourth Strong Heart study, with a mean age of 40 ± 17 years (60% women, 21% with diabetes, and 33% hypertensive). More...
Echocardiography and radial applanation tonometry were performed in all participants, and left ventricular mass was calculated using an anatomically validated formula (adjusted for height). Brachial blood pressure was measured according to a standardized protocol, and central pressures were derived using a generalized transfer function.

The results showed that all blood pressure variables were significantly related to left ventricular absolute and relative wall thickness and left ventricular mass index, with considerable variation in correlation coefficients. Central systolic pressures were uniformly more strongly related to left ventricular wall thickness, diastolic vessel diameter, and mass index, than their respective pulse pressures. Left ventricular relative wall thickness and mass index were also more strongly related to central than to brachial pulse pressures. The study was published in the February 2010 issue of the Journal of Hypertension.

"Central pressures are more strongly related than brachial pressures to concentric left ventricular geometry,” concluded lead author Mary Roman, M.D., and colleagues of the division of cardiology. "These data suggest that absolute (systolic) pressure is more important in stimulating left ventricular hypertrophy and remodeling, whereas pulsatile stress (pulse pressure) is more important in causing vascular hypertrophy and atherosclerosis.”

LVH is the thickening of the myocardium of the left ventricle of the heart; while LVH itself is not a disease, it is usually a marker for disease involving the heart. Processes that can cause LVH include any disease that increases the afterload that the heart has to contract against, such as hypertension, aortic insufficiency, and aortic stenosis, as well as primary hypertrophic cardiomyopathy, a significant cause of sudden unexpected cardiac death in any age group.

Related Links:

Weill Cornell Medical College



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.